Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping?
Conditions: Brain Tumor; Brain Pathology; Epilepsy; Vascular Malformations, Brain Intervention: Sponsor: Universitaire Ziekenhuizen KU Leuven Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
Prospective Evaluation of AI R & D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
Conditions: Brain Tumor; Glioma, Malignant; Ependymoma; Oligodendroglioma; Glioblastoma Intervention: Procedure: Resection Sponsors: Ourotech, Inc.; Imperial College Healthcare NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping?
Conditions: Brain Tumor; Brain Pathology; Epilepsy; Vascular Malformations, Brain Intervention: Sponsor: Universitaire Ziekenhuizen KU Leuven Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
Prospective Evaluation of AI R & D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
Conditions: Brain Tumor; Glioma, Malignant; Ependymoma; Oligodendroglioma; Glioblastoma Intervention: Procedure: Resection Sponsors: Ourotech, Inc.; Imperial College Healthcare NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
Non-small Cell Lung Cancer With Central Nervous System Metastasis
Condition: Lung Cancer With Central Nervous System Metastasis Intervention: Other: lung cancer with brain /leptomeningeal metastasis Sponsor: National Taiwan University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD
Conditions: HER2-positive Breast Cancer; LMD Interventions: Drug: Tucatinib 150 MG; Drug: Trastuzumab; Drug: Capecitabine; Radiation: Brain & Spinal Radiation Sponsors: Sunnybrook Health Sciences Centre; Seagen Inc.; Viatris Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis
Condition: Breast Cancer Intervention: Drug: Disitamab Vedotin plus pyrotinib or naratinib Sponsor: Xi'an International Medical Center Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials